MedTrace Logo

A Study to Evaluate Safety and Health Benefits of Basis™ Among Elderly Subjects.

NCT02678611 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-08-01

No results posted yet for this study

Summary

This study will investigate the safety, tolerability and potential health benefits of the dietary supplement, Basis. There will be two doses of Basis compared to a placebo. One third of subjects will receive the low dose Basis, one third will receive the higher dose Basis and one third will receive placebo.

Conditions

  • Safety: Healthy Subjects

Interventions

DIETARY_SUPPLEMENT

Basis 250

DIETARY_SUPPLEMENT

Basis 500

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • KGK Science Inc.

    collaborator INDUSTRY

  • Elysium Health

    lead INDUSTRY

Principal Investigators

  • Tetyana Pelipyagina, MD · KGK Science Inc.

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02678611 on ClinicalTrials.gov